News Feed

AgFeed Industries Reports Year-End Equity Financing and Updates (PR Newswire)

Rodman & Renshaw - Mon, 01/05/2009 - 15:15
AgFeed Industries, Inc. , the largest commercial hog producer and the largest premix feed company in China, today announced that it will raise gross proceeds of $8.75 million through the sale to institutional investors of 5 million newly issued common stock units at $1.75 per unit under an effective Form S-3 Registration Statement.
Categories: Client Feeds

Cell Therapeutics and Spectrum Pharmaceuticals Close Transaction Forming Joint Venture to Market Zevalin in the US (PR Newswire)

Rodman & Renshaw - Mon, 01/05/2009 - 15:15
Cell Therapeutics, Inc. announced today they have closed the transaction with Spectrum Pharmaceuticals, Inc. to form a 50/50 owned joint venture, RIT Oncology LLC , to commercialize and develop Zevalin® in the United States.
Categories: Client Feeds

Rodman & Renshaw Capital Group, Inc. Announces Filing of Investor Presentation; Company to Hold Investor Conference Call to Discuss the Proposed Combination with Cowen Group, Inc. Today at 10:00 AM Eastern (Business Wire)

Rodman & Renshaw - Mon, 01/05/2009 - 15:15
NEW YORK----Rodman & Renshaw Capital Group, Inc. , today announced that it has released an investor presentation regarding its proposed combination with Cowen Group, Inc. The presentation is available through the investor relations page of Rodman’s website and includes additional details of the proposed combination.
Categories: Client Feeds

Rodman & Renshaw Capital Group, Inc. Announces It Will Release Investor Presentation at 8:00 AM Eastern on Monday, December 15, 2008 (Business Wire)

Rodman & Renshaw - Mon, 01/05/2009 - 15:15
NEW YORK----Rodman & Renshaw Capital Group, Inc. , today announced that it will release an investor presentation at 8:00 AM Eastern on Monday, December 15, 2008 regarding its proposed combination with Cowen Group, Inc.
Categories: Client Feeds

Cowen Just Says No (at Forbes.com)

Rodman & Renshaw - Mon, 01/05/2009 - 15:15
Categories: Client Feeds

Cowen Group rejects bid from Rodman & Renshaw (AP)

Rodman & Renshaw - Mon, 01/05/2009 - 15:15
Cowen Group Inc. on Monday rejected an unsolicited bid from rival Rodman & Renshaw Capital Group Inc. to buy the investment bank for nearly $100 million, or $7 per share.
Categories: Client Feeds

MarketWatch First Take: Feasting on Wall Street's weak (at MarketWatch)

Rodman & Renshaw - Mon, 01/05/2009 - 15:15
You know youve hit a new bottom when the investment bank trying to take you over has a stock price of a buck and they want to use those shares to buy half of your company, David Weidner writes.
Categories: Client Feeds

Financial Stocks: Sector set to rally; MetLife sees net boosted by investment gains (at MarketWatch)

Rodman & Renshaw - Mon, 01/05/2009 - 15:15
The U.S. financial sector was poised to start the week higher and extend Friday's rally as President-elect Barack Obama's plan to boost infrastructure spending to create jobs lifted global markets.
Categories: Client Feeds

Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $32.65 Million of Senior Convertible Notes (PR Newswire)

Rodman & Renshaw - Mon, 01/05/2009 - 15:15
Cell Therapeutics, Inc. today announced that a single institutional investor shall purchase, for $32.65 million, newly issued 10% Convertible Senior Notes due 2011 , with a conversion price of $0.137 per share.
Categories: Client Feeds

Spectrum Pharmaceuticals and Cell Therapeutics to Jointly Market ZEVALIN, a Proprietary, Marketed Oncology Drug (PR Newswire)

Rodman & Renshaw - Mon, 01/05/2009 - 15:15
Spectrum Pharmaceuticals, Inc. and Cell Therapeutics, Inc. announced today they have entered into an agreement to form a 50/50 owned joint venture, RIT Oncology LLC, to commercialize and develop ZEVALIN® in the United States.
Categories: Client Feeds
Syndicate content